IP Verse

Innate Pharma opposition analysis

COMPANY ANALYSIS

Latest patents of Innate Pharma opposed by its competitors

Patent:
EP3405495
Grant Date:
Feb 24, 2021
Title:
Neutralization Of Inhibitory Pathways In Lymphocytes
Oppositions:
1
Patent:
EP3191517
Grant Date:
Nov 4, 2020
Title:
Cross Reactive Siglec Antibodies
Oppositions:
1

Competitors of Innate Pharma

GRAF VON STOSCH, ANDREAS

HOIBERG P/S

Want to track Innate Pharma?

Feel free to send us a message here and we will get back to you